{"id":"W4393340184","doi":"10.1016/j.lungcan.2024.107557","title":"Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Eisai Canada; Eisai; Center for Clinical Trials, Japan Medical Association","keywords":"Lenvatinib; Medicine; Hazard ratio; Internal medicine; Adverse effect; Confidence interval; Oncology; Clinical trial; Gastroenterology; Cancer; Thyroid cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002397491,0.001065894,0.001980562,0.0002345659,0.000398102,0.001512022,0.000607226,0.000886823,0.00139384],"category_scores_gemma":[0.002059986,0.00031126,0.002629752,0.0004142984,0.0005665454,0.001195175,0.0004336532,0.002369267,0.0004075904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001063453,"about_ca_system_score_gemma":0.0009660858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006813905,"about_ca_topic_score_gemma":0.002624472,"domain_scores_codex":[0.9991863,0.0004019672,0.00003831161,0.0001447699,0.00007855382,0.0001500322],"domain_scores_gemma":[0.9988378,0.0002740601,0.0003345701,0.0001312036,0.00007318985,0.0003491638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6661904,0.006581481,0.102948,0.001255171,0.01375123,0.0007040544,0.0003696191,0.006006452,0.01633912,0.000570927,0.009061095,0.1762224],"study_design_scores_gemma":[0.3518197,0.1954772,0.4041601,0.0004507532,0.01570296,0.002530853,0.0006039315,0.005610953,0.004002627,0.002562765,0.01683892,0.0002391543],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888902,0.007047444,0.0002751987,0.0005865897,0.00009209156,0.0001546519,0.001552211,0.00003723437,0.001364451],"genre_scores_gemma":[0.992027,0.001907374,0.0003994126,0.0007665515,0.0001597962,0.0002598036,0.003595058,0.0000200728,0.0008650066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002397491,"threshold_uncertainty_score":0.01267928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03466082282414185,"score_gpt":0.3378925740177667,"score_spread":0.3032317511936248,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}